# A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer

> **NCT04708847** · PHASE1 · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** GYM329
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04708847
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-10
- **Primary completion:** 2022-06-03
- **Final completion:** 2023-02-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04708847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04708847, "A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04708847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*